BioSpace News Archive

Drug Development

First Patient Dosed in a Phase 1/2 Trial of Transgene’s Oncolytic Virus TG6002 Administered Intravenously in Patients with Advanced Gastrointestinal Tumors

TG6002 Has Multiple Mechanisms of Action for Enhanced Anti-Tumor Activity: Oncolysis, Local Production of Chemotherapy in Tumor and Cell-Mediated Immune Response.

October 17, 2018
·
6 min read
Drug Development

Oligomerix Awarded $1.98 Million NIH SBIR Phase IIb Grant to Advance its Lead using Transgenic Models for Alzheimer’s Disease and Frontotemporal Dementia

Oligomerix, Inc. announced today the award of a Small Business Innovation Research Phase IIb grant for $1.98 million from the National Institutes of Health, National Institute on Aging.

October 17, 2018
·
2 min read
Drug Development

Acticor Biotech Raises €15.3M In a Series B Financing

New financing will enable the company to launch shortly the first Phase II clinical trial of its lead candidate ACT017 inhibiting GPVI in acute ischemic stroke.

October 17, 2018
·
4 min read
VALBIOTIS confirms its interest in the study of the intestinal microbiota, a promising field in the prevention of metabolic diseases

VALBIOTIS confirms its interest in the study of the intestinal microbiota, a promising field of investigation on innovative solutions for metabolic diseases.

October 17, 2018
·
7 min read
Canada Makes History and Cronos Group Inc. Looks Forward with Enthusiasm

Today, Canada became the first G7 country and the second country in the world to legalize cannabis sales for adult recreational use

October 17, 2018
·
3 min read
Business

Chubb Appoints Judy Gonsalves Division President of Chubb Bermuda

Chubb has appointed Judy Gonsalves Vice President of Chubb Group and Division President of Bermuda.

October 17, 2018
·
3 min read
BioMidwest

New Study Shows Abbott’s Novel Diagnostic Test has the Potential to Demonstrate Gold Standard Accuracy and Speed, Which Could Help Rule Out Heart Attacks Earlier at the Point of Care

For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians determine whether someone is having a heart attack.

October 17, 2018
·
4 min read
Business

Families Help Bounce Away Diabetes (B.A.D.) at Multiple Sky Zone Trampoline Parks During November’s Diabetes Awareness Month

Families who are #PumpedToJump to help find a cure for diabetes should join Bounce Away Diabetes (B.A.D.) at various participating Sky Zone parks across the U.S. on Sunday, November 4, from 10 a.m. – noon.

October 17, 2018
·
3 min read
Job Trends

Immune-Onc Therapeutics and University of Texas Report a Novel Target for Acute Myeloid Leukemia in Nature

Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a privately held cancer immunotherapy company dedicated to the discovery and development of novel biologic treatments for cancer patients, announced today the publication of a study in Nature (DOI: 10.1038/s41586-018-0615-z)

October 17, 2018
·
6 min read
Genetown

CannMed 2018, Country’s Premier Medical Cannabis Conference, Opens October 22nd - 24th at UCLA Luskin Center

The nation’s premier medical cannabis conference, CannMed 2018, will be held at UCLA’s Luskin Conference Center October 22-24.

October 17, 2018
·
4 min read